 The purpose of RHYME is to evaluate the safety and efficacy of ranolazine in Hypertrophic Cardiomypathy patients with chest pain or dyspnea despite treatment with standard medical therapy. This is a small, pilot, open-label non-randomized study of an approved drug for the treatment of angina in a novel patient population adult patient population with hypertrophic cardiomyopathy. 